Pelage Pharma, founded by a team of scientists from UCLA, is dedicated to addressing hair loss through innovative, non-invasive treatments. The company's core mission is to alleviate the emotional and social challenges associated with hair loss by leveraging a topical small molecule drug platform that activates hair follicle stem cells. This approach is grounded in a unique metabolic switch discovered in hair follicle stem cells, aiming to stimulate robust hair growth in both men and women.
Notable affiliated individuals include the pioneering UCLA scientists whose research underpins Pelage's technology. The company has achieved significant milestones, including the clinical testing of its treatment, which has shown promising results in stimulating hair growth. Pelage Pharma's impact lies in its potential to revolutionize the hair loss treatment market by offering a scientifically advanced, non-invasive solution that targets the root cause of hair follicle inactivity.
